Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
about
Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-AnalysisNeoadjuvant treatment for rectal cancer-A value-based proposition.Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer.Significance of Magnetic Resonance Imaging-Assessed Tumor Response for Locally Advanced Rectal Cancer Treated With Preoperative Long-Course Chemoradiation.Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rateThe best timing for administering systemic chemotherapy in patients with locally advanced rectal cancerConsolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen.An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy.Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications?Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases.SEOM Clinical Guideline of localized rectal cancer (2016).Surgical outcomes of post chemoradiotherapy unresectable locally advanced rectal cancers improve with interim chemotherapy, is FOLFIRINOX better than CAPOX?Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer.On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery.Clinical and molecular diagnosis of pathologic complete response in rectal cancer.Radiotherapy and locally advanced rectal cancer.Nonoperative management of rectal cancer.Watch and Wait: Is Surgery Always Necessary for Rectal Cancer?Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design.Total neoadjuvant therapy for rectal cancer: An emerging option.Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.[Time interval between neoadjuvant radiochemotherapy and surgery in rectal cancer : No impact on the pathologic complete response rate?][Neoadjuvant short-term radiotherapy followed by FOLFOX chemotherapy : No standard treatment for rectal cancer].Adjuvant Second-Dose Chemotherapy before Surgery for Patients with Locally Advanced Rectal Malignancy Is Not Beneficial: A Systematic Review and Meta-Analysis.Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer.Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study.Effects of local multivisceral resection for clinically locally advanced rectal cancer on long-term outcomes.Current issues of preoperative radio(chemo)therapy and its future evolution in locally advanced rectal cancer.Management of the Complete Clinical Response.Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation.Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: potential pitfalls of a multicentre observational study.Additional chemotherapy and salvage surgery for poor response to chemoradiotherapy in rectal cancers.Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.Contemporary management of locally advanced rectal cancer: Resolving issues, controversies and shifting paradigms.The good, the bad and the ugly: rectal cancers in the twenty-first century.Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes.
P2860
Q26748798-EA468D5F-8C74-41A2-B054-34450FE48790Q30251516-F8ACCD0B-7D61-4C5A-9D80-19C57CBFC7B6Q33710348-1D8F0BCD-D274-417C-BB10-C648D502B35BQ33872801-EED520F8-B093-4C0B-A707-52AC20562EFCQ36303226-4AC94558-5DB7-41AB-80C7-DEFB0179D14AQ36516445-2964F915-5656-4469-B639-6985C4C36CA7Q36616651-9DB15320-8204-4203-8007-5FE4C01D42C4Q37173767-2595C9AF-BC68-4FE9-BBE7-781C8B7F9872Q37322728-9E370CEA-B345-4C90-AD4B-B99EDE075ADAQ37432618-4EA2F23F-7855-48BD-86F6-BBAD9FB5FFF4Q37475229-05803CEF-5195-499B-BEB4-037368131A8DQ37525306-F1B66C90-6D65-4981-A1BE-A51208891E3AQ37686375-4A27E4E1-670F-43C3-8639-9FA5EBCB0183Q37715201-BC0D3E10-58B0-453F-87BC-6DA12C82C42BQ38594617-2C1C380A-295B-4381-81DF-4E0290BC0174Q38604995-442B0546-D1A4-4451-8F4E-1915E555B438Q38645219-391FB644-8ADE-4027-B628-6651F3DAC976Q38794781-056CC693-1A23-433B-B00E-D5743A3D9B09Q38801281-826FA7A5-EF9F-4E08-B488-C36F16C1C6C3Q39172475-616206D1-FE14-4749-B476-8BD6E50ED3CEQ39179402-D8BE25C5-67B3-4067-8B9C-2E8E2A2F94EDQ39267610-7B15AE31-EEA1-46B2-9BFF-40F4EF3A1E64Q39884524-5F7AD653-0C2B-4BD2-B356-176D23B36EC4Q40447688-5901C74D-CFDC-4F05-83E6-34E1929A6D85Q40531553-384CD468-6D7F-45D2-837F-8F1708030E12Q41403148-095FDF7C-BEF6-4DA2-AD46-DCAAC8C9F6C8Q47108227-8F639F78-DAFF-432C-ABD2-03DE87EB8123Q47183137-19A0906C-DAAE-43E2-9675-AB76BED1FA20Q47569204-8B33921E-9F75-47B1-BBE3-244F9402F809Q47847007-41B0C026-39EA-4554-A2E0-8440A1DE4ECEQ48587678-7279C399-AEAA-4127-AF9E-C2C51B8FCB01Q48602262-0D7A2759-7096-40EB-8883-B43F35636CBFQ49181456-3B33757E-814D-49B2-BEB4-BD565B457B70Q49564044-6B1A4E1B-7B31-4146-B882-9AF9A4051EEAQ50169401-ABAD1A1A-9DBC-4903-8834-1135EF371DC8Q50793187-C14F0786-03FF-4CE9-91CD-C8DAFA0205B1Q52642667-17FE0A24-9D2F-4E1F-8EEC-341BE902DEEAQ52653160-47B940AE-F508-41A0-85E2-B27D50260989Q53209581-43B48287-06FE-4A1D-8E93-4D4D4ABE2826Q54936297-397D2A9E-DCCF-430D-8FC5-D982BDD97A30
P2860
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Effect of adding mFOLFOX6 afte ...... a multicentre, phase 2 trial.
@ast
Effect of adding mFOLFOX6 afte ...... a multicentre, phase 2 trial.
@en
type
label
Effect of adding mFOLFOX6 afte ...... a multicentre, phase 2 trial.
@ast
Effect of adding mFOLFOX6 afte ...... a multicentre, phase 2 trial.
@en
prefLabel
Effect of adding mFOLFOX6 afte ...... a multicentre, phase 2 trial.
@ast
Effect of adding mFOLFOX6 afte ...... a multicentre, phase 2 trial.
@en
P2093
P2860
P921
P1433
P1476
Effect of adding mFOLFOX6 afte ...... : a multicentre, phase 2 trial
@en
P2093
Alessandro Fichera
Anjali S Kumar
Blase N Polite
Charles A Ternent
Daniel O Herzig
David W Dietz
Jorge E Marcet
Julio Garcia-Aguilar
Karin Avila
Madhulika G Varma
P2860
P304
P356
10.1016/S1470-2045(15)00004-2
P577
2015-07-14T00:00:00Z